Description
CVT-313 is a potent and selective inhibitor of cyclin-dependent kinase 2 (CDK2).
| Product Unit Size | Cost | Quantity | Stock |
|---|
CVT-313 is a potent and selective inhibitor of cyclin-dependent kinase 2 (CDK2).
| Cas No. | 199986-75-9 |
|---|---|
| Purity | ≥98% |
| Formula | C22H28N6O3 |
| Formula Wt. | 400.48 |
| IUPAC Name | 2,2'-({9-Isopropyl-6-[(4-methoxybenzyl)amino]-9H-purin-2-yl}imino)diethanol |
| Synonym | CVT313; Cdk2 Inhibitor III; Cyclin-dependent kinase 2 Inhibitor III |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Brooks E., Gray N., et al. CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation. J Biol Chem. 272(46):29207-11 (1997). PMID: 9360999.
Faber A., Chiles T. Inhibition of cyclin-dependent kinase-2 induces apoptosis in human diffuse large B-cell lymphomas. Cell Cycle. 6(23):2982-9 (2007). PMID: 18156799.
Btk inhibitor.
STING antagonist
Taxane synthesis intermediate.
Semi-synthetic peptide, melanocortin analog; MC...
Steroid; glucocorticoid agonist.
RARα/β agonist.
Core structure of melatonin; potential PPARγ a...
DPP4 inhibitor.
Isoflavone found in Pueraria; 5-HT2C and GABA-A...
Azoxanthone derivative; S100A12 and S100A13 inh...
Stearoyl-coA desaturase 1 inhibitor.
BHA derivative; potential Ca2+ ATPase inhibitor...
DAT inhibitor.
p53 inhibitor
Cathelicidin derivative, antimicrobial peptide,...
RET, EGFR, VEGFR2 inhibitor.
Endogenous sterol component of animal cell memb...
Pyrimidine analog; inhibits thymidylate synthas...
Synthetic steroid; glucocorticoid agonist.
5-HT1A agonist, α1-adrenergic antagonist.